Skip to main content
NCBI home page
Occupational and Environmental Medicine logoLink to Occupational and Environmental Medicine
. 1995 Jul;52(7):478–483. doi: 10.1136/oem.52.7.478

Effect of dietary intake of trimethylamine on human metabolism of the industrial catalyst dimethylethylamine.

T Lundh 1, B Akesson 1, S Skerfving 1
PMCID: PMC1128267  PMID: 7670623

Abstract

OBJECTIVES--The aim was to study the effect of trimethylamine (TMA) on the metabolism of the industrial catalyst dimethylethylamine (DMEA) to ascertain whether biological monitoring of industrial exposure to DMEA is compromised and excretion of the malodorous DMEA in sweat and urine is increased by dietary intake of TMA. METHODS--DMEA (0/25 mg) and TMA (0/300/600 mg) were given simultaneously once weekly for six weeks to five healthy volunteers. Plasma was collected before and one hour after the doses, and urine 0-2, 2-4, 4-6, 6-8, and 8-24 hours after the doses. Specimens were analysed by gas chromatography with a nitrogen sensitive detector. RESULTS--Both amines were readily absorbed from the gastrointestinal tract and excreted in urine within 24 hours (DMEA 80%; TMA 86%). Oral intake of TMA increased the DMEA content of plasma and urine dose dependently, although there were large individual differences. Plasma and urinary TMA concentrations also increased, but not dose dependently. Moreover, the findings suggested the formation of endogenous TMA, little dealkylation of DMEA and TMA, and considerable first-pass metabolism. CONCLUSIONS--Although intake of TMA reduced N-oxygenation of DMEA and TMA, total urinary DMEA values (aggregate of DMEA and its oxide DMEAO excretion) were unaffected. Thus, monitoring occupational exposure to DMEA by analysis of biological specimens is not confounded by dietary intake of TMA, provided that total urinary DMEA is monitored. Although the increased urinary and hidrotic excretion of DMEA may contribute to body odour problems, they were primarily due to TMA excretion, which is much the greater.

Full text

PDF
478

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Al-Waiz M., Ayesh R., Mitchell S. C., Idle J. R., Smith R. L. A genetic polymorphism of the N-oxidation of trimethylamine in humans. Clin Pharmacol Ther. 1987 Nov;42(5):588–594. doi: 10.1038/clpt.1987.201. [DOI] [PubMed] [Google Scholar]
  2. Al-Waiz M., Ayesh R., Mitchell S. C., Idle J. R., Smith R. L. Disclosure of the metabolic retroversion of trimethylamine N-oxide in humans: a pharmacogenetic approach. Clin Pharmacol Ther. 1987 Dec;42(6):608–612. doi: 10.1038/clpt.1987.207. [DOI] [PubMed] [Google Scholar]
  3. Al-Waiz M., Ayesh R., Mitchell S. C., Idle J. R., Smith R. L. Trimethylaminuria ('fish-odour syndrome'): a study of an affected family. Clin Sci (Lond) 1988 Mar;74(3):231–236. doi: 10.1042/cs0740231. [DOI] [PubMed] [Google Scholar]
  4. Al-Waiz M., Mitchell S. C., Idle J. R., Smith R. L. The metabolism of 14C-labelled trimethylamine and its N-oxide in man. Xenobiotica. 1987 May;17(5):551–558. doi: 10.3109/00498258709043962. [DOI] [PubMed] [Google Scholar]
  5. Albrecht W. N., Stephenson R. L. Health hazards of tertiary amine catalysts. Scand J Work Environ Health. 1988 Aug;14(4):209–219. doi: 10.5271/sjweh.1930. [DOI] [PubMed] [Google Scholar]
  6. Ayesh R., Smith R. L. Genetic polymorphism of trimethylamine N-oxidation. Pharmacol Ther. 1990;45(3):387–401. doi: 10.1016/0163-7258(90)90074-c. [DOI] [PubMed] [Google Scholar]
  7. Bickel M. H. N-oxide formation and related reactions in drug metabolism. Xenobiotica. 1971 Jul-Oct;1(4):313–319. doi: 10.3109/00498257109041493. [DOI] [PubMed] [Google Scholar]
  8. Hansen M. K., Larsen M., Cohr K. H. Waterborne paints. A review of their chemistry and toxicology and the results of determinations made during their use. Scand J Work Environ Health. 1987 Dec;13(6):473–485. doi: 10.5271/sjweh.2010. [DOI] [PubMed] [Google Scholar]
  9. Lundh T., Akesson B. Gas chromatographic determination of primary and secondary low-molecular-mass aliphatic amines in urine using derivatization with isobutyl chloroformate. J Chromatogr. 1993 Aug 11;617(2):191–196. doi: 10.1016/0378-4347(93)80487-o. [DOI] [PubMed] [Google Scholar]
  10. Lundh T., Ståhlbom B., Akesson B. Dimethylethylamine in mould core manufacturing: exposure, metabolism, and biological monitoring. Br J Ind Med. 1991 Mar;48(3):203–207. doi: 10.1136/oem.48.3.203. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Ståhlbom B., Lundh T., Akesson B. Experimental study on the metabolism of dimethylethylamine in man. Int Arch Occup Environ Health. 1991;63(5):305–310. doi: 10.1007/BF00381579. [DOI] [PubMed] [Google Scholar]
  12. Ståhlbom B., Lundh T., Florén I., Akesson B. Visual disturbances in man as a result of experimental and occupational exposure to dimethylethylamine. Br J Ind Med. 1991 Jan;48(1):26–29. doi: 10.1136/oem.48.1.26. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Svensson B. G., Akesson B., Nilsson A., Paulsson K. Urinary excretion of methylamines in men with varying intake of fish from the Baltic Sea. J Toxicol Environ Health. 1994 Apr;41(4):411–420. doi: 10.1080/15287399409531853. [DOI] [PubMed] [Google Scholar]

Articles from Occupational and Environmental Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES